Skip to main content
OpenTrials

Clinical trial condition

Immunoproliferative Disorders

Explore clinical trials studying Immunoproliferative Disorders. Study availability and eligibility vary by location and protocol.

9,977 public trials 2,028 recruiting studies
Refine in advanced search Browse all conditions

Immunoproliferative Disorders trial results

Completed

Chlorambucil or Fludarabine as First-Line Therapy in Treating Patients With Previously Untreated Waldenström Macroglobulinemia, Splenic Lymphoma, or Lymphoplasmacytic Lymphoma

NCT00608374

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +17 more
Locations
  • Canberra Hospital Garran, Australian Capital Territory, Australia
  • Newcastle Mater Misericordiae Hospital Waratah, New South Wales, Australia
  • Princess Alexandra Hospital Brisbane, Queensland, Australia
  • Queen Elizabeth Hospital Woodville, South Australia, Australia
View all 49 locations
View Trial Details
Completed

Quality of Life in Children Treated for Cancer

NCT00005881

Conditions
Burkitt Lymphoma, DNA Virus Infections, Dendritic Cell Sarcoma, Interdigitating, +27 more
Locations
  • Cancer Center and Beckman Research Institute, City of Hope Duarte, California, United States
  • CCOP - Bay Area Tumor Institute Oakland, California, United States
  • CCOP - Colorado Cancer Research Program, Inc. Denver, Colorado, United States
  • CCOP - Christiana Care Health Services Wilmington, Delaware, United States
View all 17 locations
View Trial Details
Completed

Combination Chemotherapy in Treating Children With Relapsed Acute Lymphoblastic Leukemia

NCT00002816

Conditions
Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
Locations
  • Long Beach Memorial Medical Center Long Beach, California, United States
  • Children's Hospital Los Angeles Los Angeles, California, United States
  • Jonsson Comprehensive Cancer Center, UCLA Los Angeles, California, United States
  • Children's Hospital of Orange County Orange, California, United States
View all 33 locations
View Trial Details
Completed

Combination Chemotherapy in Treating Patients With Non-Hodgkin's Lymphoma or Acute Lymphocytic Leukemia

NCT00005977

Conditions
Burkitt Lymphoma, DNA Virus Infections, Epstein-Barr Virus Infections, +16 more
Locations
  • University of Alabama at Birmingham Comprehensive Cancer Center Birmingham, Alabama, United States
  • University of South Alabama Medical Center Mobile, Alabama, United States
  • MBCCOP - Gulf Coast Mobile, Alabama, United States
  • Arizona Cancer Center Tucson, Arizona, United States
View all 119 locations
View Trial Details
Completed

Rituximab in Treating Patients With Waldenstrom's Macroglobulinemia

NCT00005609

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
Locations
  • CCOP - Scottsdale Oncology Program Scottsdale, Arizona, United States
  • Cancer Center and Beckman Research Institute, City of Hope Duarte, California, United States
  • Veterans Affairs Medical Center - Palo Alto Palo Alto, California, United States
  • Stanford University Medical Center Stanford, California, United States
View all 69 locations
View Trial Details
Completed

Melphalan+Prednisolon With or Without Thalidomide in Previously Untreated Elderly Patients With Multiple Myeloma

NCT00934154

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Baskent University School of Medicine Education and Research Hospital, Hematology Department Adana, Turkey (Türkiye)
  • Ankara Numune Education and Research Hospital,Hematology Department Ankara, Turkey (Türkiye)
  • Ankara University School of Medicine, Hematology Department Ankara, Turkey (Türkiye)
  • Gazi University School of Medicine, Hematology Department Ankara, Turkey (Türkiye)
View Trial Details

Related conditions